Glasgow Researchers Harness AI to Combat Colon Cancer

Engineers have shown that it is technically possible to use an AI system to guide a tiny robotic capsule inside the colon to take microultrasound images. Known as a ‘Sonopill’, the device could spell the end for painful endoscopic examinations for patients, where a semi-rigid scope is passed into the bowel. The micro ultrasound images captured by the Sonopill are also better able to identify...

Scottish Pavilion at MEDICA – Recruitment now open

MEDICA 2019 Nov 18 – Nov 21, 2019 Messe Dusseldorf, Germany Scottish Development International will once again be organising a Scottish Pavilion at MEDICA, the world’s largest and most prestigious medical technology and equipment show (www.medica.de). A world-renowned leading medical products and services show, MEDICA offers the opportunity to promote your products and services for export to an international audience and meet customers and qualified...

Secretary of State for Health and Social Care visits next generation MRI scanners

Secretary of State for Health and Social Care, Matt Hancock, visited the University of Aberdeen to see first-hand the development of the next generation of MRI scanners. Last week (May 30), Mr Hancock visited the Medical Physics department where the first full body MRI scanner was designed and built in the 1980s. Head of department, Professor David Lurie, gave Mr Hancock an overview of the...

Biotech firm Omega gets £630,000 shares lift

OMEGA Diagnostics has raised more than £630,000 from a placing of new ordinary shares. The allergy testing specialist, which received the backing from a small number of significant investors, said it would use the proceeds for working capital. Richard Sneller and Harwood Capital LLP signed up for 3,000,000 and 1,847,950 subscription shares respectively. Both are already substantial shareholders of the Clackmannanshire company. Read the full...

Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents

Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug Administration (FDA) has approved the commercialization of seven additional blood bank reagents for extended antigen typing, completing the Company’s core product offering to the US market. The new products are: Monoclonal Antisera ALBAclone® Anti-K ALBAclone® Anti-Fya ALBAclone® Anti-Jka ALBAclone® Anti-Jkb ALBAclone® Anti-S ALBAclone® Anti-s ALBAclone® Anti-P1 In March 2018, seven Quotient...

Life Sciences Company of the Year Award – Terumo Aortic

Congratulations to Terumo Aortic who won the Life Sciences Company of the Year Award at this year’s ‘Made in Scotland Awards’ on May 9th. Terumo Aortic has developed a comprehensive portfolio of products manufactured in Inchinnan, Renfrewshire. The business is composed of the combination of Renfrewshire-based Vascutek with Bolton Medical, both of which are subsidiaries of the Terumo Corporation of Japan. Read more about Vaskutek...

Top